Cancer Research UK/United Kingdom[Grant Number] - Search Results

Year	Number of Results
1983	2
1984	1
1985	3
1987	11
1988	6
1989	9
1990	11
1991	7
1992	9
1993	14
1994	13
1995	8
1996	10
1997	9
1998	9
1999	11
2000	23
2001	26
2002	21
2003	25
2004	43
2005	52
2006	93
2007	232
2008	1256
2009	1658
2010	1985
2011	2211
2012	2330
2013	2381
2014	2251
2015	2334
2016	2100
2017	1699
2018	1866
2019	1932
2020	1953
2021	380

1

Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.

Slotman BJ, van Tinteren H, Praag JO, Knegjens JL, El Sharouni SY, Hatton M, Keijser A, Faivre-Finn C, Senan S. Slotman BJ, et al. Lancet. 2015 Jan 3;385(9962):36-42. doi: 10.1016/S0140-6736(14)61085-0. Epub 2014 Sep 14. Lancet. 2015. PMID: 25230595 Free article. Clinical Trial.

2

The gut microbiota and colon cancer.

Garrett WS. Garrett WS. Science. 2019 Jun 21;364(6446):1133-1135. doi: 10.1126/science.aaw2367. Science. 2019. PMID: 31221845 No abstract available.

3

Defining dendritic cells.

Schraml BU, Reis e Sousa C. Schraml BU, et al. Curr Opin Immunol. 2015 Feb;32:13-20. doi: 10.1016/j.coi.2014.11.001. Epub 2014 Dec 3. Curr Opin Immunol. 2015. PMID: 25553392 Free article. Review.

4

Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.

McGranahan N, Swanton C. McGranahan N, et al. Cancer Cell. 2015 Jan 12;27(1):15-26. doi: 10.1016/j.ccell.2014.12.001. Cancer Cell. 2015. PMID: 25584892 Free article. Review.

5

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litière S, Hermans C, Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT; European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Judson I, et al. Lancet Oncol. 2014 Apr;15(4):415-23. doi: 10.1016/S1470-2045(14)70063-4. Epub 2014 Mar 5. Lancet Oncol. 2014. PMID: 24618336 Clinical Trial.

6

Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC).

Bradbury KE, Appleby PN, Key TJ. Bradbury KE, et al. Am J Clin Nutr. 2014 Jul;100 Suppl 1:394S-8S. doi: 10.3945/ajcn.113.071357. Epub 2014 Jun 11. Am J Clin Nutr. 2014. PMID: 24920034 Review.

7

The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015.

Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A, Deas A, Elliss-Brookes L, Gavin A, Hounsome L, Huws D, Ormiston-Smith N, Shelton J, White C, Parkin DM. Brown KF, et al. Br J Cancer. 2018 Apr;118(8):1130-1141. doi: 10.1038/s41416-018-0029-6. Epub 2018 Mar 23. Br J Cancer. 2018. PMID: 29567982 Free PMC article.

8

Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions.

Julian L, Olson MF. Julian L, et al. Small GTPases. 2014;5:e29846. doi: 10.4161/sgtp.29846. Epub 2014 Jul 10. Small GTPases. 2014. PMID: 25010901 Free PMC article. Review.

9

Genome-wide association studies of cancer: current insights and future perspectives.

Sud A, Kinnersley B, Houlston RS. Sud A, et al. Nat Rev Cancer. 2017 Nov;17(11):692-704. doi: 10.1038/nrc.2017.82. Epub 2017 Oct 13. Nat Rev Cancer. 2017. PMID: 29026206 Review.

10

Clinical management of breast cancer heterogeneity.

Zardavas D, Irrthum A, Swanton C, Piccart M. Zardavas D, et al. Nat Rev Clin Oncol. 2015 Jul;12(7):381-94. doi: 10.1038/nrclinonc.2015.73. Epub 2015 Apr 21. Nat Rev Clin Oncol. 2015. PMID: 25895611 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results